MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 14,618 Shares of Docusign Inc. $DOCU

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its stake in Docusign Inc. by 54.2%, selling 14,618 shares and ending with a total of 12,335 shares worth approximately $961,000.
• Docusign recently beat earnings expectations, reporting $0.92 earnings per share for the quarter, surpassing the consensus estimate of $0.84.
• The company's Board authorized a $1 billion stock repurchase program, which allows for the reacquisition of up to 6.6% of its outstanding shares, indicating a belief that the stock is undervalued.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH trimmed its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 54.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,335 shares of the company's stock after selling 14,618 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Docusign were worth $961,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of DOCU. Hemington Wealth Management lifted its position in shares of Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares during the last quarter. Banque Transatlantique SA bought a new stake in Docusign in the 1st quarter valued at about $26,000. Golden State Wealth Management LLC lifted its holdings in Docusign by 519.4% during the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after purchasing an additional 322 shares during the last quarter. Summit Securities Group LLC bought a new position in Docusign during the first quarter worth about $34,000. Finally, Wood Tarver Financial Group LLC bought a new position in Docusign during the fourth quarter worth about $37,000. Institutional investors own 77.64% of the company's stock.

Docusign Stock Down 3.2%

NASDAQ DOCU opened at $81.31 on Friday. The company has a 50-day simple moving average of $76.95 and a two-hundred day simple moving average of $79.41. Docusign Inc. has a 12-month low of $60.57 and a 12-month high of $107.86. The firm has a market cap of $16.35 billion, a price-to-earnings ratio of 61.14, a PEG ratio of 4.40 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. The business had revenue of $800.64 million during the quarter, compared to analysts' expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities analysts expect that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its Board of Directors has authorized a stock repurchase program on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its stock is undervalued.

Insider Buying and Selling

In related news, Director Anna Marrs sold 728 shares of Docusign stock in a transaction on Monday, September 15th. The stock was sold at an average price of $80.30, for a total value of $58,458.40. Following the completion of the sale, the director owned 10,799 shares of the company's stock, valued at $867,159.70. The trade was a 6.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director James A. Beer sold 450 shares of the firm's stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $81.28, for a total value of $36,576.00. Following the sale, the director directly owned 14,199 shares in the company, valued at approximately $1,154,094.72. This represents a 3.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 82,533 shares of company stock valued at $6,598,028 over the last 90 days. 1.01% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on DOCU shares. JMP Securities restated a "market outperform" rating and set a $124.00 target price on shares of Docusign in a research report on Friday, September 5th. Zacks Research raised Docusign from a "hold" rating to a "strong-buy" rating in a report on Tuesday, September 9th. Wall Street Zen upgraded Docusign from a "hold" rating to a "buy" rating in a research note on Saturday, September 13th. Wells Fargo & Company lifted their target price on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. Finally, Royal Bank Of Canada increased their price target on shares of Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $94.14.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.